Immunovant Inc.
24.30
1.42 (6.21%)
At close: Jan 15, 2025, 1:42 PM

Balance Sheet (Annual)

Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year FY24 FY23 FY22 FY21 FY20 FY19 FY18
Cash & Equivalents 635.37M 376.53M 493.82M 400.15M 100.57M 325.00K n/a
Short-Term Investments n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets n/a n/a n/a n/a 246.00K 79.95K n/a
Receivables 5.50M 885.00K 12.86M 1.14M 3.04M n/a n/a
Inventory n/a -0.00 -0.00 0.00 n/a n/a n/a
Other Current Assets 24.90M 26.92M 6.25M 7.72M 5.46M n/a 113.17K
Total Current Assets 665.77M 404.33M 512.93M 409.01M 109.08M 325.00K 113.17K
Property-Plant & Equipment 595.00K 1.50M 2.63M 3.48M 65.00K 54.00 n/a
Goodwill & Intangibles n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets 595.00K 1.50M 2.63M 3.48M 311.00K 80.00K n/a
Total Assets 666.37M 405.84M 515.56M 412.49M 109.39M 405.00K 113.17K
Account Payables 7.16M 1.35M 18.63M 2.43M 1.19M 206.00 1.14M
Deferred Revenue n/a n/a n/a n/a -3.19M -206 n/a
Short-Term Debt 276.00K 1.17M 1.15M 2.36M 3.19M 300.00K n/a
Other Current Liabilities 41.18M 40.77M 24.75M 13.98M 10.94M 80.24K 474.02K
Total Current Liabilities 48.61M 43.30M 44.52M 18.77M 15.32M 380.45K 1.61M
Long-Term Debt n/a 47.00K 1.22M 2.24M n/a n/a n/a
Other Long-Term Liabilities -347.00K n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities n/a 47.00K 1.22M 2.24M 14.13M 300.00K n/a
Total Liabilities 48.61M 43.34M 45.74M 21.01M 15.32M 380.45K 1.61M
Total Debt 138.00K 1.22M 2.36M 3.42M 3.19M 300.00K n/a
Common Stock 14.00K 13.00K 12.00K 10.00K 5.00K 288.00 n/a
Retained Earnings -825.68M -566.35M -355.39M -198.66M -91.23M -448 n/a
Comprehensive Income 1.91M 852.00K 404.00K -298.00K -16.00K 343.00K -1.50M
Shareholders Equity 617.76M 362.49M 469.82M 391.48M 94.07M 24.55K -1.50M
Total Investments n/a n/a n/a n/a n/a n/a n/a